FDA Inspection 1252328 — AnazaoHealth Corporation
The FDA completed an inspection of AnazaoHealth Corporation on Sep 23, 2024 in Las Vegas, NV. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 23, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Las Vegas, NV (United States)